1. Home
  2. MLTX vs JANX Comparison

MLTX vs JANX Comparison

Compare MLTX & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • JANX
  • Stock Information
  • Founded
  • MLTX 2021
  • JANX 2017
  • Country
  • MLTX Switzerland
  • JANX United States
  • Employees
  • MLTX N/A
  • JANX N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • JANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MLTX Health Care
  • JANX Health Care
  • Exchange
  • MLTX Nasdaq
  • JANX Nasdaq
  • Market Cap
  • MLTX 3.4B
  • JANX 3.6B
  • IPO Year
  • MLTX N/A
  • JANX 2021
  • Fundamental
  • Price
  • MLTX $54.83
  • JANX $57.91
  • Analyst Decision
  • MLTX Strong Buy
  • JANX Strong Buy
  • Analyst Count
  • MLTX 9
  • JANX 11
  • Target Price
  • MLTX $77.43
  • JANX $83.09
  • AVG Volume (30 Days)
  • MLTX 170.7K
  • JANX 1.6M
  • Earning Date
  • MLTX 11-07-2024
  • JANX 11-06-2024
  • Dividend Yield
  • MLTX N/A
  • JANX N/A
  • EPS Growth
  • MLTX N/A
  • JANX N/A
  • EPS
  • MLTX N/A
  • JANX N/A
  • Revenue
  • MLTX N/A
  • JANX $13,049,000.00
  • Revenue This Year
  • MLTX N/A
  • JANX $40.27
  • Revenue Next Year
  • MLTX N/A
  • JANX N/A
  • P/E Ratio
  • MLTX N/A
  • JANX N/A
  • Revenue Growth
  • MLTX N/A
  • JANX 54.12
  • 52 Week Low
  • MLTX $37.55
  • JANX $7.79
  • 52 Week High
  • MLTX $64.98
  • JANX $71.71
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 59.60
  • JANX 55.16
  • Support Level
  • MLTX $50.60
  • JANX $58.96
  • Resistance Level
  • MLTX $58.26
  • JANX $66.34
  • Average True Range (ATR)
  • MLTX 2.44
  • JANX 5.13
  • MACD
  • MLTX 0.11
  • JANX 0.10
  • Stochastic Oscillator
  • MLTX 72.58
  • JANX 61.47

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.

Share on Social Networks: